These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 26848800)
21. VCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy? Smith NE; Deyrup AT; Mariño-Enriquez A; Fletcher JA; Bridge JA; Illei PB; Netto GJ; Argani P Am J Surg Pathol; 2014 Jun; 38(6):858-63. PubMed ID: 24698962 [TBL] [Abstract][Full Text] [Related]
22. Oncogenic ALK Fusion in Rare and Aggressive Subtype of Colorectal Adenocarcinoma as a Potential Therapeutic Target. Yakirevich E; Resnick MB; Mangray S; Wheeler M; Jackson CL; Lombardo KA; Lee J; Kim KM; Gill AJ; Wang K; Gowen K; Sun J; Miller VA; Stephens PJ; Ali SM; Ross JS; Safran H Clin Cancer Res; 2016 Aug; 22(15):3831-40. PubMed ID: 26933125 [TBL] [Abstract][Full Text] [Related]
23. A Novel Malignant Peritoneal Mesothelioma with STRN Exon 2 and ALK Exon 20: A Case Report and Literature Review. Miyagawa C; Takaya H; Sakai K; Nishio K; Konishi M; Minamiguchi S; Shimada T; Matsumura N Oncologist; 2021 May; 26(5):356-361. PubMed ID: 33555117 [TBL] [Abstract][Full Text] [Related]
24. ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients. Sukov WR; Hodge JC; Lohse CM; Akre MK; Leibovich BC; Thompson RH; Cheville JC Mod Pathol; 2012 Nov; 25(11):1516-25. PubMed ID: 22743654 [TBL] [Abstract][Full Text] [Related]
25. Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum. Debelenko LV; Raimondi SC; Daw N; Shivakumar BR; Huang D; Nelson M; Bridge JA Mod Pathol; 2011 Mar; 24(3):430-42. PubMed ID: 21076462 [TBL] [Abstract][Full Text] [Related]
26. Clinicopathologic and Molecular Pathology of Collecting Duct Carcinoma and Related Renal Cell Carcinomas. Seo AN; Yoon G; Ro JY Adv Anat Pathol; 2017 Mar; 24(2):65-77. PubMed ID: 28181950 [TBL] [Abstract][Full Text] [Related]
27. Bulutay P; Vatansever D; Taskiran C; Mericoz CA; Tokat F; Kapucuoglu N; Kulac I Indian J Pathol Microbiol; 2023; 66(2):392-395. PubMed ID: 37077094 [TBL] [Abstract][Full Text] [Related]
28. Mouse Model of Poorly Differentiated Thyroid Carcinoma Driven by STRN-ALK Fusion. Nikitski AV; Rominski SL; Wankhede M; Kelly LM; Panebianco F; Barila G; Altschuler DL; Nikiforov YE Am J Pathol; 2018 Nov; 188(11):2653-2661. PubMed ID: 30125543 [TBL] [Abstract][Full Text] [Related]
29. Reticular Myxoid Odontogenic Neoplasm with Novel STRN::ALK Fusion: Report of 2 Cases in 3-Year-Old Males. Rosebush MS; Smith MH; Cordell KG; Callahan N; Zaid W; Gagan J; Bishop JA Head Neck Pathol; 2024 Mar; 18(1):26. PubMed ID: 38526831 [TBL] [Abstract][Full Text] [Related]
30. ALK-TPM3 rearrangement in adult renal cell carcinoma: Report of a new case showing loss of chromosome 3 and literature review. Bodokh Y; Ambrosetti D; Kubiniek V; Tibi B; Durand M; Amiel J; Pertuit M; Barlier A; Pedeutour F Cancer Genet; 2018 Feb; 221():31-37. PubMed ID: 29405994 [TBL] [Abstract][Full Text] [Related]
32. TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum. Rao Q; Williamson SR; Zhang S; Eble JN; Grignon DJ; Wang M; Zhou XJ; Huang W; Tan PH; Maclennan GT; Cheng L Am J Surg Pathol; 2013 Jun; 37(6):804-15. PubMed ID: 23598965 [TBL] [Abstract][Full Text] [Related]
33. [Anaplastic lymphoma kinase-translocation renal cell carcinoma: clinical and pathological analysis]. Di SH; Wang XT; Xia QY; Lu ZF; Ma HH; Zhang RS; Wang X; Rao Q Zhonghua Bing Li Xue Za Zhi; 2022 Jan; 51(1):28-32. PubMed ID: 34979750 [No Abstract] [Full Text] [Related]
34. TFE3-positive renal cell carcinomas are not always Xp11 translocation carcinomas: Report of a case with a TPM3-ALK translocation. Thorner PS; Shago M; Marrano P; Shaikh F; Somers GR Pathol Res Pract; 2016 Oct; 212(10):937-942. PubMed ID: 27450657 [TBL] [Abstract][Full Text] [Related]
35. An Xp11.2 translocation renal cell carcinoma with SMARCB1 (INI1) inactivation in adult end-stage renal disease: a case report. Yu L; Li J; Xu S; Navia Miranda M; Wang G; Duan Y Diagn Pathol; 2016 Oct; 11(1):98. PubMed ID: 27733182 [TBL] [Abstract][Full Text] [Related]
36. Characterization of thyroid cancer driven by known and novel ALK fusions. Panebianco F; Nikitski AV; Nikiforova MN; Kaya C; Yip L; Condello V; Wald AI; Nikiforov YE; Chiosea SI Endocr Relat Cancer; 2019 Nov; 26(11):803-814. PubMed ID: 31539879 [TBL] [Abstract][Full Text] [Related]
38. Novel gene fusion of PRCC-MITF defines a new member of MiT family translocation renal cell carcinoma: clinicopathological analysis and detection of the gene fusion by RNA sequencing and FISH. Xia QY; Wang XT; Ye SB; Wang X; Li R; Shi SS; Fang R; Zhang RS; Ma HH; Lu ZF; Shen Q; Bao W; Zhou XJ; Rao Q Histopathology; 2018 Apr; 72(5):786-794. PubMed ID: 29148086 [TBL] [Abstract][Full Text] [Related]
39. Ciliated Muconodular Papillary Tumors of the Lung Harboring Zhang X; Yuan W; Luo R; Luan L; Huang J; Lu S; Sujie A; Hou Y Int J Surg Pathol; 2024 Oct; 32(7):1357-1363. PubMed ID: 38321754 [TBL] [Abstract][Full Text] [Related]
40. Detection of an Lai AZ; Schrock AB; Erlich RL; Ross JS; Miller VA; Yakirevich E; Ali SM; Braiteh F Oncologist; 2017 Jul; 22(7):774-779. PubMed ID: 28507204 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]